The Medicines and Healthcare products Regulatory Agency (MHRA) aims to ensure that medicines, healthcare products and medical equipment meet appropriate standards of safety, quality, performance and effectiveness. It
The multi-center, open label, phase IIb study is being conducted by Cancer Trials Australia at three institutions, including Melbourne’s Austin Health, Royal Melbourne Hospital and the Peter MacCallum
The phase I dose escalation study treated 22 patients with advanced solid tumors. All patients had previously been treated for cancer, and the majority had received surgery in
The anti-CD55 antibody is under an exclusive option from Cancer Research Technology (UK), and is being developed for the treatment of a broad range of solid tumors. These
The FDA licensed Menactra vaccine in January for use among 11 through 55 year olds. Sanofi Pasteur has now filed a supplemental application with the FDA to amend
Following recent regulatory setbacks for Marqibo (vincristine sulfate liposomes injection), and after a careful evaluation, Enzon determined it will not support further development of the product. In January
This application of IGF-1 receptor antagonists complements Insmed and UCSF’s ongoing clinical studies with INSM-18, a small molecule IGF-1 tyrosine kinase inhibitor in a phase I clinical study
HuMy9-6-DM4, a tumor-activated prodrug (TAP) compound, comprises the engineered antibody huMy9-6, which binds specifically to the CD33 target found on acute myeloid leukemia cancer cells, and DM4, a
For the first time in this disease area, researchers at the Serono Genetics Institute (SGI) have identified 80 genes involved in the inflammatory and neuro-degenerative pathways of multiple
Predix will receive up to $12.5 million in milestone-driven funds over the next three years through a therapeutics development award from Cystic Fibrosis Foundation Therapeutics (CFFT). The award
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.